Answers are grounded in this paper and cite their sources.
In scientific research, animal modelling of human disease is pivotal in both studying the mechanisms of the disease and developing potential therapies. An imbalance in the interaction between the endocannabinoid (eCB) and Neurotransmitter (NT) systems may play a role in the pathogenesis of neurological diseases, such as Parkinson’s Disease (PD). The major limitation of current neurochemical practice is that different assays are used to measure each class of NTs.
No takes yet. Share an insight, caveat, or question.
Maria et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: